Xenon Pharmaceuticals (XENE) Other Non Operating Income (2013 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly Other Non Operating Income came in at $548000.0 in Q1 2026, up 1465.71% year-on-year from $35000.0 in Q1 2025, and up 285.14% on a QoQ basis from -$296000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Other Non Operating Income (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 14 years of Other Non Operating Income data on file, last reported at $548000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 1465.71% year-over-year to $548000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 255.6% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 226.69% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $548000.0, up from -$296000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for XENE reached as high as $1.7 million in Q2 2025 and fell as low as -$2.4 million in Q3 2022.
- Historically, Other Non Operating Income has averaged -$50588.2 across 5 years, with a median of $35000.0 in 2025.
- Across the five-year window, Other Non Operating Income tumbled 1760.16% in 2022 and surged 16880.0% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $602000.0 in 2022, then plunged by 114.95% to -$90000.0 in 2023, then tumbled by 1542.22% to -$1.5 million in 2024, then surged by 79.97% to -$296000.0 in 2025, then surged by 285.14% to $548000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $548000.0 in Q1 2026, -$296000.0 in Q4 2025, and -$89000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 548,000.00 |
| Dec 31, 2025 | -296,000.00 |
| Sep 30, 2025 | -89,000.00 |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 167,000.00 |
| Dec 31, 2023 | -90,000.00 |
| Sep 30, 2023 | -407,000.00 |
| Jun 30, 2023 | 383,000.00 |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 602,000.00 |
| Sep 30, 2022 | -2.38 Mn |
| Jun 30, 2022 | -411,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | 214,000.00 |
| Sep 30, 2021 | -128,000.00 |
| Jun 30, 2021 | 117,000.00 |